In addition to clinical predictors, such as age, sex, and a history of cardiovascular disease and hypertension (negative risk), we determined that NT-proBNP, cholinesterase, and albumin were among the most significant prognostic markers in the entire cohort. This evidence concerns the gene NPPB and hypertensive disorder.